Ovid Therapeutics Inc.(OVID)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

OVID Ovid Therapeutics Inc.

盘后交易 03-18 17:12:45 EDT

2.30

+0.29

+14.43%

盘后2.34

+0.04+1.77%

17:11 EDT

最高2.50	最低2.22	成交量4,063万
今开2.41	昨收2.01	日振幅13.93%
总市值2.99亿	流通市值1.37亿	总股本1.30亿
成交额9,684万	换手率68.26%	流通股本5,952万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"OVID","market":"US","secType":"STK","nameCN":"Ovid Therapeutics Inc.","latestPrice":2.3,"timestamp":1773864000000,"preClose":2.01,"halted":0,"volume":40633476,"hourTrading":{"tag":"盘后","latestPrice":2.3406,"preClose":2.3,"latestTime":"17:11 EDT","volume":109938,"amount":255669.61404,"timestamp":1773868299563,"change":0.0406,"changeRate":0.017652,"amplitude":0.026087},"delay":0,"changeRate":0.14427860696517417,"floatShares":59524501,"shares":130184400,"eps":-0.504739,"marketStatus":"盘后交易","change":0.29,"latestTime":"03-18 17:12:45 EDT","open":2.41,"high":2.5,"low":2.22,"amount":96841657.7037624,"amplitude":0.139303,"askPrice":2.36,"askSize":44,"bidPrice":2.34,"bidSize":1420,"shortable":3,"etf":0,"ttmEps":-0.504739,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1773878400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1493956800000,"exchange":"NASDAQ","adjPreClose":2.01,"preHourTrading":{"tag":"盘前","latestPrice":2.4,"preClose":2.01,"latestTime":"09:29 EDT","volume":8082577,"amount":19930454.825758003,"timestamp":1773840599999,"change":0.39,"changeRate":0.19403,"amplitude":0.442786},"postHourTrading":{"tag":"盘后","latestPrice":2.3406,"preClose":2.3,"latestTime":"17:11 EDT","volume":109938,"amount":255669.61404,"timestamp":1773868299563,"change":0.0406,"changeRate":0.017652,"amplitude":0.026087},"volumeRatio":38.428328,"impliedVol":1.1,"impliedVolPercentile":0.6096},"requestUrl":"/m/hq/s/OVID","defaultTab":"news","newsList":[{"id":"1175259141","title":"Ovid Therapeutics癫痫新药安全性数据积极 盘前股价飙升26.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1175259141","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175259141?lang=zh_cn&edition=full","pubTime":"2026-03-18 18:23","pubTimestamp":1773829419,"startTime":"0","endTime":"0","summary":"Ovid Therapeutics Inc.今日盘前交易中股价大幅上涨26.4%，此前该公司公布了其实验性癫痫药物OV935/TAK-935的积极安全性数据。该数据来自一项针对发育性和癫痫性脑病患者的二期临床试验。此次公布的安全性数据涉及药物在儿科患者中的长期使用表现。该积极数据不仅推动Ovid股价上涨，也带动了生物技术板块的整体情绪。根据最新披露的机构持仓数据，多家对冲基金在近期增持了Ovid股票。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OVID"],"gpt_icon":0},{"id":"1179199055","title":"Ovid Therapeutics现金储备达9040万美元 神经疾病药物研发资金充足","url":"https://stock-news.laohu8.com/highlight/detail?id=1179199055","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179199055?lang=zh_cn&edition=full","pubTime":"2026-03-18 18:08","pubTimestamp":1773828510,"startTime":"0","endTime":"0","summary":"Ovid Therapeutics Inc.最新财报显示，截至2025年12月31日，公司持有现金、现金等价物及有价证券总额达9040万美元。这一数据为后续神经疾病创新药研发提供了明确的资金保障。相较同行，近期多家中小型生物科技公司因资金链问题削减研发支出，Ovid的现金状况为其在神经疾病靶点竞争中获得差异化优势提供了支撑。财报发布后，Ovid股价在盘后交易中波动幅度小于1%，反映市场对现金规模的预期已充分消化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OVID"],"gpt_icon":0},{"id":"1146770854","title":"Ovid Therapeutics公布Ov329新数据及适应症扩展，Ov4071获一期临床许可，同时披露2025年第四季度及全年财报","url":"https://stock-news.laohu8.com/highlight/detail?id=1146770854","media":"美股速递","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146770854?lang=zh_cn&edition=full","pubTime":"2026-03-18 18:05","pubTimestamp":1773828328,"startTime":"0","endTime":"0","summary":"生物制药公司Ovid Therapeutics Inc.近日宣布其核心候选药物Ov329取得新的临床数据，并计划扩大适应症范围。同时，公司另一款在研药物Ov4071已获得美国食品药品监督管理局的一期临床试验许可。此次公告还涵盖了公司2025年第四季度及全年的财务业绩。市场观察人士指出，对于像Ovid这样处于临床阶段的生物技术公司，其股价表现主要与研发管线中的里程碑事件挂钩。Ov329新数据的披露以及Ov4071进入临床阶段，被视作积极的催化因素。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OVID","BK4139"],"gpt_icon":0},{"id":"1197058561","title":"Ra Capital Management, L.p.于12月11日报告持有Ovid Therapeutics 9.9%的被动股份 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1197058561","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197058561?lang=zh_cn&edition=full","pubTime":"2025-12-19 07:12","pubTimestamp":1766099529,"startTime":"0","endTime":"0","summary":"Ra Capital Management, L.p.于12月11日报告持有Ovid Therapeutics 9.9%的被动股份 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OVID","BK4139"],"gpt_icon":0},{"id":"2581090530","title":"Ovid Therapeutics Inc.盘中异动 早盘快速拉升5.26%报1.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581090530","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581090530?lang=zh_cn&edition=full","pubTime":"2025-11-06 22:59","pubTimestamp":1762441193,"startTime":"0","endTime":"0","summary":"北京时间2025年11月06日22时59分，Ovid Therapeutics Inc.股票出现异动，股价急速上涨5.26%。截至发稿，该股报1.40美元/股，成交量10.923万股，换手率0.15%，振幅5.64%。Ovid Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Ovid Therapeutics Inc.公司简介：Ovid Therapeutics Inc是一家生物制药公司，致力于减少癫痫发作并切实改善被罕见癫痫和癫痫相关神经系统疾病影响的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110622595397586b5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110622595397586b5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","BK4539","LENZ","OVID"],"gpt_icon":0},{"id":"2578221386","title":"Ovid Therapeutics Inc.盘中异动 早盘股价大涨5.52%报1.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2578221386","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578221386?lang=zh_cn&edition=full","pubTime":"2025-10-27 21:31","pubTimestamp":1761571885,"startTime":"0","endTime":"0","summary":"北京时间2025年10月27日21时31分，Ovid Therapeutics Inc.股票出现异动，股价快速上涨5.52%。截至发稿，该股报1.72美元/股，成交量9.0333万股，换手率0.13%，振幅4.29%。Ovid Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.52%。Ovid Therapeutics Inc.公司简介：Ovid Therapeutics Inc是一家生物制药公司，致力于减少癫痫发作并切实改善被罕见癫痫和癫痫相关神经系统疾病影响的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510272131259744d9d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510272131259744d9d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","OVID","BK4139","LENZ"],"gpt_icon":0},{"id":"2577902103","title":"Ovid Therapeutics Inc.盘中异动 下午盘快速下挫5.00%报1.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577902103","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577902103?lang=zh_cn&edition=full","pubTime":"2025-10-23 01:30","pubTimestamp":1761154223,"startTime":"0","endTime":"0","summary":"北京时间2025年10月23日01时30分，Ovid Therapeutics Inc.股票出现波动，股价急速下挫5.00%。截至发稿，该股报1.52美元/股，成交量69.8321万股，换手率0.98%，振幅5.63%。Ovid Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.80%。Ovid Therapeutics Inc.公司简介：Ovid Therapeutics Inc是一家生物制药公司，致力于减少癫痫发作并切实改善被罕见癫痫和癫痫相关神经系统疾病影响的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023013023973cf81e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023013023973cf81e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","BK4539","LENZ","OVID"],"gpt_icon":0},{"id":"2575079865","title":"Ovid Therapeutics Inc.盘中异动 股价大跌5.14%报1.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575079865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575079865?lang=zh_cn&edition=full","pubTime":"2025-10-16 01:04","pubTimestamp":1760547852,"startTime":"0","endTime":"0","summary":"北京时间2025年10月16日01时04分，Ovid Therapeutics Inc.股票出现异动，股价快速下挫5.14%。截至发稿，该股报1.66美元/股，成交量91.7318万股，换手率1.29%，振幅5.71%。Ovid Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.61%。Ovid Therapeutics Inc.公司简介：Ovid Therapeutics Inc是一家生物制药公司，致力于减少癫痫发作并切实改善被罕见癫痫和癫痫相关神经系统疾病影响的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101601041294cb42fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101601041294cb42fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","OVID","BK4539","LENZ"],"gpt_icon":0},{"id":"2575138244","title":"Ovid Therapeutics Inc.盘中异动 急速拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575138244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575138244?lang=zh_cn&edition=full","pubTime":"2025-10-15 00:52","pubTimestamp":1760460740,"startTime":"0","endTime":"0","summary":"北京时间2025年10月15日00时52分，Ovid Therapeutics Inc.股票出现异动，股价大幅上涨5.02%。Ovid Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Ovid Therapeutics Inc.公司简介：Ovid Therapeutics Inc是一家生物制药公司，致力于减少癫痫发作并切实改善被罕见癫痫和癫痫相关神经系统疾病影响的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015005220a6b952c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015005220a6b952c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OVID","BK4007","BK4539","LENZ"],"gpt_icon":0},{"id":"1190529035","title":"Ovid Therapeutics宣布其新一代癫痫药物取得积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1190529035","media":"老虎资讯综合","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190529035?lang=zh_cn&edition=full","pubTime":"2025-10-03 19:21","pubTimestamp":1759490515,"startTime":"0","endTime":"0","summary":"10月3日，$Ovid Therapeutics$盘前一度飙涨40%！此前该公司宣布其新一代GABA-氨基转移酶抑制剂OV329的顶线结果呈阳性，显示出强大的抑制活性和潜在的同类最佳安全性。这项针对68名健康志愿者的I期试验表明，OV329在多项指标上实现了对GABA-AT的统计学显著抑制。\"Ovid计划在2026年第二季度将OV329推进到针对药物耐药性局灶性发作的IIa期研究。该公司还在推进其KCC2直接激活剂产品组合，其首个口服候选药物OV4071预计将于2026年初提交监管申请。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"1d91b7ba967b27adf4977540771cf3d8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Ovid Therapeutics宣布其新一代癫痫药物取得积极结果","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","OVID","BK4139","BK4539"],"gpt_icon":1},{"id":"1153229989","title":"Ovid Therapeutics宣布完成私募配售定价 总收益最高可达1.75亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1153229989","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153229989?lang=zh_cn&edition=full","pubTime":"2025-10-03 19:06","pubTimestamp":1759489573,"startTime":"0","endTime":"0","summary":"Ovid Therapeutics宣布完成私募配售定价，本次私募配售的总收益最高可达1.75亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OVID"],"gpt_icon":0},{"id":"1111612338","title":"Ovid公布下一代GABA氨基转移酶抑制剂Ov329积极的顶线结果，显示出强效抑制活性和潜在的同类最佳安全性特征","url":"https://stock-news.laohu8.com/highlight/detail?id=1111612338","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111612338?lang=zh_cn&edition=full","pubTime":"2025-10-03 19:01","pubTimestamp":1759489276,"startTime":"0","endTime":"0","summary":"Ovid Therapeutics Inc.公布了其下一代GABA氨基转移酶抑制剂Ov329的积极顶线结果，研究数据显示该药物具有强效的抑制活性，并展现出潜在的同类最佳安全性特征。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"1d91b7ba967b27adf4977540771cf3d8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OVID"],"gpt_icon":0},{"id":"1129376214","title":"Ovid Therapeutics 2024年第四季度 GAAP每股收益 $-0.13 优于 $-0.16 的预期，每股销售额 $76K 低于 $189.286K 的预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1129376214","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129376214?lang=zh_cn&edition=full","pubTime":"2025-03-11 20:52","pubTimestamp":1741697552,"startTime":"0","endTime":"0","summary":"Ovid Therapeutics(LENZ) 2024年第四季度的GAAP每股收益为$-0.13，优于预期的$-0.16，每股销售额为$76K，低于预期的$189.286K。以上内容来自Benzinga Earnings专栏，原文如下：Ovid $Therapeutics(LENZ)$ Q4 2024 GAAP EPS $(0.13) Beats $(0.16) Estimate, Sales $76K Miss $189.286K Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OVID","LENZ"],"gpt_icon":0},{"id":"2518275516","title":"Ovid Therapeutics Inc.股价飙升11.65% 市值涨182.33万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518275516","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518275516?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:33","pubTimestamp":1741613604,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时33分，Ovid Therapeutics Inc.股票出现波动，股价急速上涨11.65%。截至发稿，该股报0.580美元/股，成交量2.52万股，换手率0.04%，振幅3.91%。Ovid Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Ovid Therapeutics Inc.公司简介：Ovid Therapeutics Inc 是一家生物制药公司，致力于减少癫痫发作并切实改善罕见癫痫和癫痫相关神经系统疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213325a26a2559&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213325a26a2559&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OVID","LENZ"],"gpt_icon":0},{"id":"2517192832","title":"Ovid Therapeutics Inc.盘中异动 快速拉升5.10%报0.528美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517192832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517192832?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:43","pubTimestamp":1741290185,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时43分，Ovid Therapeutics Inc.股票出现异动，股价大幅拉升5.10%。截至发稿，该股报0.528美元/股，成交量13.9828万股，换手率0.20%，振幅5.06%。Ovid Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.59%。Ovid Therapeutics Inc.公司简介：Ovid Therapeutics Inc 是一家生物制药公司，致力于减少癫痫发作并切实改善罕见癫痫和癫痫相关神经系统疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307034305989eea1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307034305989eea1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","OVID"],"gpt_icon":0},{"id":"2517560762","title":"Ovid Therapeutics Inc.盘中异动 下午盘股价大涨5.62%报0.521美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517560762","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517560762?lang=zh_cn&edition=full","pubTime":"2025-03-05 02:16","pubTimestamp":1741112194,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日02时16分，Ovid Therapeutics Inc.股票出现异动，股价大幅上涨5.62%。截至发稿，该股报0.521美元/股，成交量8.643万股，换手率0.12%，振幅6.67%。Ovid Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Ovid Therapeutics Inc.公司简介：Ovid Therapeutics Inc 是一家生物制药公司，致力于减少癫痫发作并切实改善罕见癫痫和癫痫相关神经系统疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030502163496397b48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030502163496397b48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","OVID"],"gpt_icon":0},{"id":"2516652557","title":"Ovid Therapeutics Inc.盘中异动 下午盘大幅跳水5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516652557","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516652557?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:33","pubTimestamp":1741026834,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时33分，Ovid Therapeutics Inc.股票出现波动，股价大幅跳水5.66%。Ovid Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.64%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4397.50%、193.93%、179.44%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Ovid Therapeutics Inc.公司简介：Ovid Therapeutics Inc 是一家生物制药公司，致力于减少癫痫发作并切实改善罕见癫痫和癫痫相关神经系统疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304023355abe67919&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304023355abe67919&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","OVID"],"gpt_icon":0},{"id":"2514862290","title":"Ovid Therapeutics Inc.盘中异动 临近收盘股价大跌6.48%报0.530美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514862290","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514862290?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:40","pubTimestamp":1740602428,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时40分，Ovid Therapeutics Inc.股票出现波动，股价急速下跌6.48%。截至发稿，该股报0.530美元/股，成交量17.1169万股，换手率0.24%，振幅8.33%。Ovid Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.69%。Ovid Therapeutics Inc.公司简介：Ovid Therapeutics Inc 是一家生物制药公司，致力于减少癫痫发作并切实改善罕见癫痫和癫痫相关神经系统疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270440289631902b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270440289631902b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","OVID","BK4139"],"gpt_icon":0},{"id":"2514480090","title":"Ovid Therapeutics Inc.盘中异动 早盘股价大涨7.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514480090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514480090?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:38","pubTimestamp":1740494297,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时38分，Ovid Therapeutics Inc.股票出现异动，股价急速上涨7.92%。Ovid Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Organovo Holdings, Inc.、Silexion Therapeutics Corp、Adial Pharmaceuticals, Inc涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为811.97%、579.16%、502.98%，振幅较大的相关个股有Organovo Holdings, Inc.、Gt Biopharma, Inc.、Moleculin Biotech, Inc.，振幅分别为100.27%、33.50%、20.56%。Ovid Therapeutics Inc.公司简介：Ovid Therapeutics Inc 是一家生物制药公司，致力于减少癫痫发作并切实改善罕见癫痫和癫痫相关神经系统疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223817962ff43a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223817962ff43a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","OVID","BK4139"],"gpt_icon":0},{"id":"2513727839","title":"Ovid Therapeutics Inc.盘中异动 股价大涨5.65%报0.652美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513727839","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513727839?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:37","pubTimestamp":1740407853,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时37分，Ovid Therapeutics Inc.股票出现波动，股价快速上涨5.65%。截至发稿，该股报0.652美元/股，成交量7.0325万股，换手率0.10%，振幅1.86%。Ovid Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Ovid Therapeutics Inc.公司简介：Ovid Therapeutics Inc 是一家生物制药公司，致力于减少癫痫发作并切实改善罕见癫痫和癫痫相关神经系统疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223733a25215cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223733a25215cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OVID","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ovidrx.com","stockEarnings":[{"period":"1week","weight":-0.0563},{"period":"1month","weight":0.4155},{"period":"3month","weight":0.3581},{"period":"6month","weight":0.6475},{"period":"1year","weight":3.3124},{"period":"ytd","weight":0.2331}],"compareEarnings":[{"period":"1week","weight":-0.0094},{"period":"1month","weight":-0.0161},{"period":"3month","weight":-0.0009},{"period":"6month","weight":0.0129},{"period":"1year","weight":0.1827},{"period":"ytd","weight":-0.0163}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ovid Therapeutics Inc.根据特拉华州法律于2014年4月1日成立。该公司是一家专注于为患有罕见神经系统疾病的患者和家庭开发有影响力的药物的生物制药公司。该公司认为，这些疾病是药物开发的一个有吸引力的领域，因为在过去几年中对潜在生物学的理解已经有意义的增长;但仍被行业忽视。其经验丰富的团队开始了将罕见神经病学的生物学和症状学整合的愿景，为其候选药物的开发采用创新研究和临床策略。使用遗传学和大脑生物学途径的最新科学进步，该公司已经创建了疾病相关途径的蓝图，以鉴定和获得用于治疗罕见神经系统疾病的新化合物。该公司正在执行其战略，在许可证领域与领先的生物制药公司和学术机构合作。该公司正在开发一个强大的临床资产管道，最初的重点是神经发育障碍和罕见的癫痫性脑病。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.020873},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.066362},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.011914},{"month":4,"riseRate":0.625,"avgChangeRate":0.117495},{"month":5,"riseRate":0.375,"avgChangeRate":-0.043003},{"month":6,"riseRate":0.444444,"avgChangeRate":-0.00562},{"month":7,"riseRate":0.555556,"avgChangeRate":0.100859},{"month":8,"riseRate":0.333333,"avgChangeRate":0.120758},{"month":9,"riseRate":0.444444,"avgChangeRate":0.073183},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.098533},{"month":11,"riseRate":0.666667,"avgChangeRate":0.229624},{"month":12,"riseRate":0.222222,"avgChangeRate":-0.162183}],"exchange":"NASDAQ","name":"Ovid Therapeutics Inc.","nameEN":"Ovid Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ovid Therapeutics Inc.(OVID)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ovid Therapeutics Inc.(OVID)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ovid Therapeutics Inc.,OVID,Ovid Therapeutics Inc.股票,Ovid Therapeutics Inc.股票老虎,Ovid Therapeutics Inc.股票老虎国际,Ovid Therapeutics Inc.行情,Ovid Therapeutics Inc.股票行情,Ovid Therapeutics Inc.股价,Ovid Therapeutics Inc.股市,Ovid Therapeutics Inc.股票价格,Ovid Therapeutics Inc.股票交易,Ovid Therapeutics Inc.股票购买,Ovid Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ovid Therapeutics Inc.(OVID)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ovid Therapeutics Inc.(OVID)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}